Journal History

2022

The inaugural issue was released. Drugs and Drug Candidates was published as a quarterly journal.

Drugs and Drug Candidates established the following sections:
Marketed Drugs
In Silico Approaches in Drug Discovery
Medicinal Chemistry and Preliminary Screening
Preclinical Research
Clinical Research
Intellectual Property, Regulatory Affairs, and Market Analysis

2024

Drugs and Drug Candidates established the following sections:
Drug Candidates from Natural Sources
Biologics

Editor-in-Chief

2022–present Editor-in-Chief: Dr. Jean Jacques Vanden Eynde

Section Editor-in-Chief

2024–present Section Editor-in-Chief: Dr. François Marceau for the section on Biologics
Section Editor-in-Chief:
Dr. Fatma Sezer Senol Deniz for the section on Drug Candidates from Natural Sources
Section Editor-in-Chief
: Prof. Dr. Osvaldo Andrade Santos-Filho for the section on In Silico Approaches in Drug Discovery
Section Editor-in-Chief
: Prof. Dr. Philippe Loiseau for the section on Medicinal Chemistry and Preliminary Screening
Back to TopTop